Forschung
Lehre
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Pharmacology & Therapeutics,
Department of Pharmacology and Therapeutics
David W. Goodrich has not added Biography.
If you are David W. Goodrich and would like to personalize this page please email our Author Liaison for assistance.
How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein.
Journal of cellular physiology Nov, 2003 | Pubmed ID: 14502556
The retinoblastoma tumor-suppressor gene, the exception that proves the rule.
Oncogene Aug, 2006 | Pubmed ID: 16936742
The Thoc1 ribonucleoprotein and prostate cancer progression.
Journal of the National Cancer Institute Nov, 2014 | Pubmed ID: 25296641
Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice.
Molecular and cellular biology 06, 2016 | Pubmed ID: 27001308
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.
Science (New York, N.Y.) 01, 2017 | Pubmed ID: 28059767
An approach for controlling the timing and order of engineered mutations in mice.
Genesis (New York, N.Y. : 2000) 08, 2018 | Pubmed ID: 30113769
Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells.
The Prostate Feb, 2019 | Pubmed ID: 30280407
Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy.
Trends in cancer 05, 2019 | Pubmed ID: 31174843
Vitamin D3 Metabolites Demonstrate Prognostic Value in -Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance.
Cancers Mar, 2020 | Pubmed ID: 32183160
Pan-cancer molecular analysis of the RB tumor suppressor pathway.
Communications biology 04, 2020 | Pubmed ID: 32242058
Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in -Mutant Non-small Cell Lung Cancer.
Frontiers in genetics , 2020 | Pubmed ID: 32292420
Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.
PloS one , 2021 | Pubmed ID: 33481853
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer.
Science advances 04, 2021 | Pubmed ID: 33827814
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity.
Cancer cell 08, 2021 | Pubmed ID: 34270926
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
Molecular cancer therapeutics May, 2022 | Pubmed ID: 35247903
Retinoblastoma Protein Paralogs and Tumor Suppression.
Frontiers in genetics , 2022 | Pubmed ID: 35368709
Roswell Park Comprehensive Cancer Center
Dongbo Xu1,
Li Wang1,
Kyle Wieczorek1,
Yanqing Wang2,
Xiaojing Zhang2,
David W. Goodrich2,
Qiang Li1,2
1Department of Urology, Roswell Park Comprehensive Cancer Center,
2Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center
Kristine M. Wadosky1,
Yanqing Wang1,
Xiaojing Zhang1,
David W. Goodrich1
1Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten